A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
24 May 2024
Historique:
received: 08 02 2024
accepted: 14 05 2024
medline: 24 5 2024
pubmed: 24 5 2024
entrez: 24 5 2024
Statut: epublish

Résumé

Patients with lung cancer can experience significant psychological morbidities including depression. We characterize patterns and factors associated with interventions for symptoms of depression in stage IV non-small cell lung cancer (NSCLC). We conducted a population-based cohort study using health services administrative data in Ontario, Canada of stage IV NSCLC diagnosed from January 2007 to September 2018. A positive symptom of depression score was defined by reporting at least one ESAS (Edmonton Symptom Assessment System) depression score ≥ 2 following diagnosis until the end of follow-up (September 2019). Patient factors included age, sex, comorbidity burden, rurality of residence, and neighbourhood income quintile. Interventions included psychiatry assessment, psychology referral, social work referral and anti-depressant medical therapy (for patients ≥ 65 years with universal drug coverage). Multivariable modified Poisson regression models were used to examine the association between patient factors and intervention use for patients who reported symptoms of depression. In the cohort of 13,159 patients with stage IV NSCLC lung cancer, symptoms of depression were prevalent (71.4%, n = 9,397). Patients who reported symptoms of depression were more likely to receive psychiatry assessment/psychology referral (7.8% vs 3.5%; SD [standardized difference] 0.19), social work referral (17.4% vs 11.9%; SD 0.16) and anti-depressant prescriptions (23.8% vs 13.8%; SD 0.26) when compared to patients who did not report symptoms of depression respectively. In multivariable analyses, older patients were less likely to receive any intervention. Females were more likely to obtain a psychiatry assessment/psychology referral or social work referral. In addition, patients from non-major urban or rural residences were less likely to receive psychiatry assessment/psychology referral or social work referral, however patients from rural residences were more likely to be prescribed anti-depressants. There is high prevalence of symptoms of depression in stage IV NSCLC. We identify patient populations, including older patients and rural patients, who are less likely to receive interventions that will help identifying and screening for symptoms of depression.

Identifiants

pubmed: 38787434
doi: 10.1007/s00520-024-08584-2
pii: 10.1007/s00520-024-08584-2
doi:

Substances chimiques

Antidepressive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

381

Informations de copyright

© 2024. Crown.

Références

Zabora J, BrintzenhofeSzoc K, Curbow B et al (2001) The prevalence of psychological distress by cancer site. Psychooncology 10:19–28. https://doi.org/10.1002/1099-1611(200101/02)10:1%3c19::aid-pon501%3e3.0.co;2-6
doi: 10.1002/1099-1611(200101/02)10:1<19::aid-pon501>3.0.co;2-6 pubmed: 11180574
Arrieta O, Angulo LP, Núñez-Valencia C et al (2013) Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol 20:1941–1948. https://doi.org/10.1245/s10434-012-2793-5
doi: 10.1245/s10434-012-2793-5 pubmed: 23263699
Lo C, Calzavara A, Kurdyak P et al (2013) Depression and use of health care services in patients with advanced cancer. Can Fam Physician 59:e168–e174
pubmed: 23486819 pmcid: 3596227
Choi S, Ryu E (2018) Effects of symptom clusters and depression on the quality of life in patients with advanced lung cancer. Eur J Cancer Care (Engl) 27:. https://doi.org/10.1111/ecc.12508
Polański J, Chabowski M, Chudiak A et al (2018) Intensity of Anxiety and Depression in Patients with Lung Cancer in Relation to Quality of Life. Adv Exp Med Biol 1023:29–36. https://doi.org/10.1007/5584_2017_50
doi: 10.1007/5584_2017_50 pubmed: 28573442
Grotmol KS, Lie HC, Loge JH et al (2019) Patients with advanced cancer and depression report a significantly higher symptom burden than non-depressed patients. Palliat Support Care 17:143–149. https://doi.org/10.1017/S1478951517001183
doi: 10.1017/S1478951517001183 pubmed: 29317008
Walker J, Hansen CH, Martin P et al (2014) Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry 1:343–350. https://doi.org/10.1016/S2215-0366(14)70313-X
doi: 10.1016/S2215-0366(14)70313-X pubmed: 26360998
Hui D, Bruera E (2017) The Edmonton Symptom Assessment System 25 Years Later: Past, Present and Future Developments. J Pain Symptom Manage 53:630–643. https://doi.org/10.1016/J.JPAINSYMMAN.2016.10.370
doi: 10.1016/J.JPAINSYMMAN.2016.10.370 pubmed: 28042071
Kotronoulas G, Kearney N, Maguire R et al (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 32:1480–1501. https://doi.org/10.1200/JCO.2013.53.5948
doi: 10.1200/JCO.2013.53.5948 pubmed: 24711559
Barbera L, Sutradhar R, Seow H et al (2020) The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population-based retrospective matched cohort analysis. Cancer Med 9:7107–7115. https://doi.org/10.1002/CAM4.3374
doi: 10.1002/CAM4.3374 pubmed: 32794634 pmcid: 7541161
Howell D, Keshavarz H, Esplen MJ, et al (2015) Pan-Canadian practice guideline: screening, assessment and management of psychosocial distress, depression and anxiety in adults with cancer. Can Partnersh Against Cancer, Can Assoc Psychosoc Oncol
Howell D, Molloy S, Wilkinson K et al (2015) Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol Off J Eur Soc Med Oncol 26:1846–1858. https://doi.org/10.1093/ANNONC/MDV181
doi: 10.1093/ANNONC/MDV181
Tjong MC, Doherty M, Tan H et al (2021) Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer. Oncologist 26:e1800–e1811. https://doi.org/10.1002/ONCO.13890
doi: 10.1002/ONCO.13890 pubmed: 34216415 pmcid: 8488785
Yan M, Tjong M, Chan WC et al (2023) Dyspnea in patients with stage IV non-small cell lung cancer: a population-based analysis of disease burden and patterns of care. J Thorac Dis 15:494–506. https://doi.org/10.21037/jtd-22-919
Tan VS, Tjong MC, Chan WC et al (2023) Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide Analysis. Curr Oncol 30:3461–3472. https://doi.org/10.3390/curroncol30030262
doi: 10.3390/curroncol30030262 pubmed: 36975475 pmcid: 10047317
Azzalini L, Chabot-Blanchet M, Southern DA et al (2019) A disease-specific comorbidity index for predicting mortality in patients admitted to hospital with a cardiac condition. CMAJ 191:E299–E307. https://doi.org/10.1503/CMAJ.181186/-/DC1
doi: 10.1503/CMAJ.181186/-/DC1 pubmed: 30885968 pmcid: 6422783
Jawitz OK, Wang Z, Boffa DJ et al (2017) The differential impact of preoperative comorbidity on perioperative outcomes following thoracoscopic and open lobectomies. Eur J Cardiothorac Surg 51:169–174. https://doi.org/10.1093/EJCTS/EZW239
doi: 10.1093/EJCTS/EZW239 pubmed: 27458143
Kralj B (2000) Measuring “rurality” for purposes of health-care planning: an empirical measure for Ontario. Ont Med Rev 67:33–52
Rhondali W, Perceau E, Berthiller J et al (2012) Frequency of depression among oncology outpatients and association with other symptoms. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 20:2795–2802. https://doi.org/10.1007/s00520-012-1401-3
doi: 10.1007/s00520-012-1401-3
Hallet J, Davis LE, Isenberg-Grzeda E et al (2020) Gaps in the Management of Depression Symptoms Following Cancer Diagnosis: A Population-Based Analysis of Prospective Patient-Reported Outcomes. Oncologist 25:e1098. https://doi.org/10.1634/THEONCOLOGIST.2019-0709
doi: 10.1634/THEONCOLOGIST.2019-0709 pubmed: 32100906 pmcid: 7356756
Noel CW, Sutradhar R, Chan WC, et al (2023) Gaps in Depression Symptom Management for Patients With Head and Neck Cancer. Laryngoscope https://doi.org/10.1002/lary.30595
Bubis LD, Davis L, Mahar A et al (2018) Symptom Burden in the First Year After Cancer Diagnosis: An Analysis of Patient-Reported Outcomes. J Clin Oncol 36:1103–1111. https://doi.org/10.1200/JCO.2017.76.0876
doi: 10.1200/JCO.2017.76.0876 pubmed: 29494259
Davis LE, Gupta V, Allen-Ayodabo C, et al (2020) Patient-reported symptoms following diagnosis in esophagus cancer patients treated with palliative intent. Dis esophagus Off J Int Soc Dis Esophagus 33:. https://doi.org/10.1093/dote/doz108
Hammad A, Davis LE, Mahar AL et al (2019) Symptom trajectories and predictors of severe symptoms in pancreatic adenocarcinoma at the end-of-life: a population based analysis of 2,538 patients. HPB (Oxford, England) 21:1744–1752. https://doi.org/10.1016/j.hpb.2019.04.016
doi: 10.1016/j.hpb.2019.04.016
Monteith LL, Holliday R, Brown TL et al (2021) Preventing Suicide in Rural Communities During the COVID-19 Pandemic. J Rural Heal Off J Am Rural Heal Assoc Natl Rural Heal Care Assoc 37:179–184. https://doi.org/10.1111/jrh.12448
doi: 10.1111/jrh.12448
Stewart H, Jameson JP, Curtin L (2015) The relationship between stigma and self-reported willingness to use mental health services among rural and urban older adults. Psychol Serv 12:141–148. https://doi.org/10.1037/a0038651
doi: 10.1037/a0038651 pubmed: 25602504
Thomas D, Macdowell M, Glasser M (2012) Rural mental health workforce needs assessment - a national survey. Rural Remote Health 12:2176
pubmed: 23088609
Muench U, Jura M, Thomas CP et al (2022) Rural-urban prescribing patterns by primary care and behavioral health providers in older adults with serious mental illness. BMC Health Serv Res 22:1440. https://doi.org/10.1186/s12913-022-08813-6
doi: 10.1186/s12913-022-08813-6 pubmed: 36447260 pmcid: 9706942
Salk RH, Hyde JS, Abramson LY (2017) Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms. Psychol Bull 143:783–822. https://doi.org/10.1037/bul0000102
doi: 10.1037/bul0000102 pubmed: 28447828 pmcid: 5532074
Sullivan DR, Forsberg CW, Ganzini L et al (2016) Depression symptom trends and health domains among lung cancer patients in the CanCORS study. Lung Cancer 100:102–109. https://doi.org/10.1016/j.lungcan.2016.08.008
doi: 10.1016/j.lungcan.2016.08.008 pubmed: 27597288
Park S, Kang CH, Hwang Y et al (2016) Risk factors for postoperative anxiety and depression after surgical treatment for lung cancer†. Eur J cardio-thoracic Surg Off J Eur Assoc Cardio-thoracic Surg 49:e16-21. https://doi.org/10.1093/ejcts/ezv336
doi: 10.1093/ejcts/ezv336
Hong JS, Tian J (2014) Prevalence of anxiety and depression and their risk factors in Chinese cancer patients. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 22:453–459. https://doi.org/10.1007/s00520-013-1997-y
doi: 10.1007/s00520-013-1997-y
Bubis LD, Delibasic V, Davis LE et al (2020) Patient-reported symptoms in metastatic gastric cancer patients in the last 6 months of life. Support Care Cancer 29:515–524. https://doi.org/10.1007/s00520-020-05501-1
doi: 10.1007/s00520-020-05501-1 pubmed: 32415385
Merchant SJ, Kong W, Brundage M, Booth CM (2020) Symptom Evolution in Patients with Esophageal and Gastric Cancer Receiving Palliative Chemotherapy: A Population-Based Study. Ann Surg Oncol 28:79–87. https://doi.org/10.1245/s10434-020-09289-6
doi: 10.1245/s10434-020-09289-6 pubmed: 33140252
Bubis LD, Davis LE, Canaj H et al (2020) Patient-Reported Symptom Severity Among 22,650 Cancer Outpatients in the Last Six Months of Life. J Pain Symptom Manage 59:58-66.e4. https://doi.org/10.1016/j.jpainsymman.2019.08.016
doi: 10.1016/j.jpainsymman.2019.08.016 pubmed: 31430522
Holland JC, Bultz BD (2007) The NCCN guideline for distress management: a case for making distress the sixth vital sign. J Natl Compr Canc Netw 5:3–7
doi: 10.6004/jnccn.2007.0003 pubmed: 17323529
Bultz BD, Groff SL, Fitch M et al (2011) Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psychooncology 20:463–469. https://doi.org/10.1002/pon.1932
doi: 10.1002/pon.1932 pubmed: 21456060
Wagner LI, Spiegel D, Pearman T (2013) Using the science of psychosocial care to implement the new american college of surgeons commission on cancer distress screening standard. J Natl Compr Canc Netw 11:214–221. https://doi.org/10.6004/jnccn.2013.0028
doi: 10.6004/jnccn.2013.0028 pubmed: 23411387
Pirl WF, Fann JR, Greer JA et al (2014) Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force. Cancer 120:2946–2954. https://doi.org/10.1002/cncr.28750
doi: 10.1002/cncr.28750 pubmed: 24798107
Andersen BL, Rowland JH, Somerfield MR (2015) Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an american society of clinical oncology guideline adaptation. J Oncol Pract 11:133–134. https://doi.org/10.1200/JOP.2014.002311
doi: 10.1200/JOP.2014.002311 pubmed: 25515721

Auteurs

Vivian S Tan (VS)

Department of Radiation Oncology, University of Western Ontario, London, Canada.

Michael C Tjong (MC)

Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Wing C Chan (WC)

ICES, Toronto, Canada.

Michael Yan (M)

Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Victoria Delibasic (V)

ICES, Toronto, Canada.

Gail Darling (G)

Division of Thoracic Surgery, University of Toronto, Toronto, Canada.

Laura E Davis (LE)

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.

Mark Doherty (M)

Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Canada.

Julie Hallet (J)

Department of Surgery, University of Toronto, Toronto, Canada.

Biniam Kidane (B)

Division of Thoracic Surgery, University of Manitoba, Winnipeg, Canada.

Alyson Mahar (A)

Faculty of Health Sciences, Queen's University, Kingston, ON, Canada.

Nicole Mittmann (N)

Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.

Ambica Parmar (A)

Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Canada.

Hendrick Tan (H)

Department of Radiation Oncology, GenesisCare, Perth, Australia.

Frances C Wright (FC)

Department of Surgery, University of Toronto, Toronto, Canada.

Natalie G Coburn (NG)

Department of Surgery, University of Toronto, Toronto, Canada.

Alexander V Louie (AV)

Department of Radiation Oncology, University of Toronto, Toronto, Canada. alexander.louie@sunnybrook.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH